Radiostereometric Analysis of Spine Arthrodesis

Sponsor
OAD Orthopaedics (Other)
Overall Status
Unknown status
CT.gov ID
NCT01721889
Collaborator
Halifax Biomedical Inc. (Industry), Central DuPage Hospital (Other)
30
1
38
0.8

Study Details

Study Description

Brief Summary

The primary objective of this pilot study is to determine the precision of post-operative radiostereometric measurements for the assessment of lumbar spinal fusion. This study will also determine the potential for RSA as a more precise and accurate means for assessment of lumbar spinal fusion and diagnosis of pseudarthrosis.

Condition or Disease Intervention/Treatment Phase
  • Radiation: Radiostereometric Analysis

Study Design

Study Type:
Observational
Anticipated Enrollment :
30 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Radiostereometric Analysis of Spine Arthrodesis
Study Start Date :
Nov 1, 2012
Anticipated Primary Completion Date :
Jan 1, 2015
Anticipated Study Completion Date :
Jan 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Radiostereometric analysis - Intact fusion

Clinically fused per classical radiographic assessment (≤ 2 degrees angular motion and evidence of bone bridging)

Radiation: Radiostereometric Analysis
The radiostereometric (RSA) patient exam (flexion and extension RSA images) presents additional radiation exposure to the patient above standard of care (additional radiographs). Assuming 120kV, using three protocols (two loaded and one unloaded) per RSA exam results in a typical effective dose of approximately 2.04mSv per exam(single lumbar spine RSA at 120kV yields 0.68mSv,). HBI recommends using 140kV for lumbar spine RSA and has conducted simulations to estimate the effective dose using higher kV settings. 140kV reduces the effective dose from 0.68mSv per spine RSA to 0.2mSV, resulting in a total effective dose per RSA exam of 0.6mSv. In comparison, the estimated effective dose for a single standard lumbar spine x-ray is 1.2mSv. This additional radiation exposure is considered to be minimal risk in consideration of the number of planar x-rays the patient will undergo as part of standard care, as well as average background radiation received by humans per year (3.1mSv).

Radiostereometric analysis - Symptomatic pseudoarthrosis

Definitive clinical evidence of pseudarthrosis (not fused, ˃ 2 degrees angular motion or absence of bone bridge) and scheduled for surgical exploration

Radiation: Radiostereometric Analysis
The radiostereometric (RSA) patient exam (flexion and extension RSA images) presents additional radiation exposure to the patient above standard of care (additional radiographs). Assuming 120kV, using three protocols (two loaded and one unloaded) per RSA exam results in a typical effective dose of approximately 2.04mSv per exam(single lumbar spine RSA at 120kV yields 0.68mSv,). HBI recommends using 140kV for lumbar spine RSA and has conducted simulations to estimate the effective dose using higher kV settings. 140kV reduces the effective dose from 0.68mSv per spine RSA to 0.2mSV, resulting in a total effective dose per RSA exam of 0.6mSv. In comparison, the estimated effective dose for a single standard lumbar spine x-ray is 1.2mSv. This additional radiation exposure is considered to be minimal risk in consideration of the number of planar x-rays the patient will undergo as part of standard care, as well as average background radiation received by humans per year (3.1mSv).

Radiostereometric analysis - Asymptomatic pseudoarthrosis

Definitive clinical evidence of pseudarthrosis without scheduled surgical exploration.

Radiation: Radiostereometric Analysis
The radiostereometric (RSA) patient exam (flexion and extension RSA images) presents additional radiation exposure to the patient above standard of care (additional radiographs). Assuming 120kV, using three protocols (two loaded and one unloaded) per RSA exam results in a typical effective dose of approximately 2.04mSv per exam(single lumbar spine RSA at 120kV yields 0.68mSv,). HBI recommends using 140kV for lumbar spine RSA and has conducted simulations to estimate the effective dose using higher kV settings. 140kV reduces the effective dose from 0.68mSv per spine RSA to 0.2mSV, resulting in a total effective dose per RSA exam of 0.6mSv. In comparison, the estimated effective dose for a single standard lumbar spine x-ray is 1.2mSv. This additional radiation exposure is considered to be minimal risk in consideration of the number of planar x-rays the patient will undergo as part of standard care, as well as average background radiation received by humans per year (3.1mSv).

Outcome Measures

Primary Outcome Measures

  1. Intervertebral motion post-op lumbar fusion [2 years]

    The purpose of this radiostereometric analysis (RSA) evaluation is to measure relative intervertebral motion in lumbar spinal fusions. Two RSA loading provocation protocols will be employed in this study; sitting and supine extension. Both loading protocols will be compard to a standard supine position which is used as an unloaded baseline protocol. Induced intervetebral motion sets will be calculated between the two loaded states, sitting and supine extension, and the unloaded state. The RSA micromotion results will be calculated and reported as translations and rotations about the three anatomic axes, maximum total point motion (MTPM) will be calculated as well.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Symptomatic degenerative disc disease of the lumbar spine indication surgical intervention

  • Scheduled to undergo lumbar fusion surgery

  • Patients between the ages of 18 and 75

  • Ability to give informed consent

Exclusion Criteria:
  • Pregnant women

Contacts and Locations

Locations

Site City State Country Postal Code
1 OAD Orthopaedics Warrenville Illinois United States 60555

Sponsors and Collaborators

  • OAD Orthopaedics
  • Halifax Biomedical Inc.
  • Central DuPage Hospital

Investigators

  • Principal Investigator: John Andreshak, MD, OAD Orthopaedics

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
OAD Orthopaedics
ClinicalTrials.gov Identifier:
NCT01721889
Other Study ID Numbers:
  • RSA100
First Posted:
Nov 6, 2012
Last Update Posted:
Jun 11, 2013
Last Verified:
Jun 1, 2013
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 11, 2013